General Information
Version
.00
Revision date
2023-07-26
Product name
Firocoxib Chewable Tablets 57 mg and 227mg
1.2.1 Relevant identified uses
Firocoxib Chewable Tablets are indicated for the control of pain and inflammation associated with osteoarthritis and for the control of postoperative pain and inflammation associated with soft-tissue and orthopedic surgery in dogs
Emergency telephone
1-833-571-1525
Icons in SDS
Company Information
company name
of the Responsible Party
Section 2
SECTION 2: Hazards identification
Classification (GHS-US) Classification of the Substance or Mixture Classification (GHS-US) This product is a drug, as defined by the US Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.). It is in solid, final form for direct administration to the patient. Therefore, it is exempt from the US 2012 Hazard Communication Standard, as defined in the 29 CFR 1910.1200(b)(6)(vii)
2.2 Label elements
No labeling applicable
2.3 Other hazards
No additional information available
Ingredient(s) with unknown acute toxicity
No data available
2.1 Classification of the substance or mixture
Classification (GHS-US) This product is a drug, as defined by the US Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.). It is in solid, final form for direct administration to the patient. Therefore, it is exempt from the US 2012 Hazard Communication Standard, as defined in the 29 CFR 1910.1200(b)(6)(vii).